EPIAO®

DRUG3 trials

Sponsors

Xiamen Amoytop Biotech Co., Ltd., Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

HealthyRenal AnaemiaRenal Anemia

Phase 1

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

CompletedNCT01800305

Xiamen Amoytop Biotech Co., Ltd.Healthy

Start: 2012-09-30End: 2014-10-31Updated: 2015-08-31

Phase 3

Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)

CompletedNCT02947438

Shenyang Sunshine Pharmaceutical Co., LTD.Renal Anemia

Start: 2015-12-31End: 2021-10-09Updated: 2022-11-23

Phase 4

Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)

TerminatedNCT02522975

Shenyang Sunshine Pharmaceutical Co., LTD.Renal Anaemia

Start: 2015-08-31End: 2019-08-31Updated: 2020-10-22